• 1
    Costenbader KH, Brome D, Blanch D, et al. Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study. Arthritis Rheum. 2007; 57: 4955.
  • 2
    Israni AK, Halpern SD, McFadden C, et al. Willingness of dialysis patients to participate in a randomized controlled trial of daily dialysis. Kidney Int. 2004; 65: 990998.
  • 3
    Halpern SD, Karlawish JH, Casarett D, et al. Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. Arch Intern Med. 2004; 164: 801803.
  • 4
    Ding EL, Powe NR, Manson JE, et al. Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials. Arch Intern Med. 2007; 167: 905912.
  • 5
    Watson JM, Torgerson DJ. Increasing recruitment to randomised trials: a review of randomized controlled trials. BMC Med Res Methodol. 2006; 6: 34.
  • 6
    Jowett SL, Seal CJ, Barton JR, et al. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol. 2001; 96: 29212928.
    Direct Link:
  • 7
    Halpern SD, Karlawish JH, Casarett D, et al. Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency. Am Heart J. 2003; 146: 985992.